Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 6Genitourinary 5Gastrointestinal 5Sarcoma 3Breast 3Thoracic 2Head & Neck 2Gynecologic 2Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 3Seroma 1Recurrence 1Neoplasm Metastasis 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Congresses as Topic × Breast × Clear all
NCT02387099 2022-02-23

Desiree

GBG Forschungs GmbH

Phase 2 Completed
156 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT00262834 2020-02-19

Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 7 charts
Breast

Breast Neoplasms

NCT03305757 2019-12-03

SAM

Zuyderland Medisch Centrum

Phase 4 Completed
339 enrolled
Breast

Breast Neoplasms, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡